Mike, To help us find what medication works best for your low mood, use the MyMeds app to monitor your wellbeing and securely update me with emails.
ok. I'll use the app to keep you updated. See you in 2 weeks Dr Tom.
Patient does questionnaires in comfort of own home
Welcome to the free my meds app. Let's complete wellbeing questionnaires to see how medication helps and then email them to your doctor.
email Dr results
together with your professional, you'll be able to make smarter decisions about your meds
Because your data only ever stays on your phone, you're in control of who sees it. You choose which individual professionals you want to share it with via secure NHS email, depending on who is providing your care.
2 weeks later...
patient and dr share insights & make smarter prescribing decision
From the email I see your wellbeing has improved by 30% on fluoxetine 20mg. A quick and easy automated way to take the guesswork out of prescribing to improve evidence-based decisions. All without spending time chasing paper forms.
I'm happy that I've found the right medication for me. And I can see how it's working.
And I can use the outcome audit trail to build my professional portfolio.
management increases patient throughput
As clinical director, for the first time, I can see how effective my clinicians are. Because data collection is automated, the data is inexepensive to collect and frees up clinicians to see more patients to save money. I can now reward high-performing clinicians and address low-performing professionals whilst monitoring drug expenditures to improve governance.
It helped me choose the right medication for me.
I can prescribe using the individual' evidence-base quickly and simply.
I can give better care whilst saving time and money
Sell Trade Name Drug Outcome Dataset to Relevant Pharmaceuticals
I'm in control... I can also show my data to another doctor if I want to
as the 64.7m people in the UK taking antidepressants start to use the platform, unprecedented big data on drug benefits is captured and sold to large pharmaceuticals to expand use cases for their existing line of drugs.